Your browser doesn't support javascript.
loading
Gallbladder Cancer Risk and Indigenous South American Mapuche Ancestry: Instrumental Variable Analysis Using Ancestry-Informative Markers.
Zollner, Linda; Boekstegers, Felix; Barahona Ponce, Carol; Scherer, Dominique; Marcelain, Katherine; Gárate-Calderón, Valentina; Waldenberger, Melanie; Morales, Erik; Rojas, Armando; Munoz, César; Retamales, Javier; De Toro, Gonzalo; Kortmann, Allan Vera; Barajas, Olga; Rivera, María Teresa; Cortés, Analía; Loader, Denisse; Saavedra, Javiera; Gutiérrez, Lorena; Ortega, Alejandro; Bertrán, Maria Enriqueta; Bartolotti, Leonardo; Gabler, Fernando; Campos, Mónica; Alvarado, Juan; Moisán, Fabricio; Spencer, Loreto; Nervi, Bruno; Carvajal, Daniel; Losada, Héctor; Almau, Mauricio; Fernández, Plinio; Olloquequi, Jordi; Carter, Alice R; Miquel Poblete, Juan Francisco; Bustos, Bernabe Ignacio; Fuentes Guajardo, Macarena; Gonzalez-Jose, Rolando; Bortolini, Maria Cátira; Acuña-Alonzo, Victor; Gallo, Carla; Ruiz Linares, Andres; Rothhammer, Francisco; Lorenzo Bermejo, Justo.
Afiliação
  • Zollner L; Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, 69120 Heidelberg, Germany.
  • Boekstegers F; Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center, 69120 Heidelberg, Germany.
  • Barahona Ponce C; Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, 69120 Heidelberg, Germany.
  • Scherer D; Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, 69120 Heidelberg, Germany.
  • Marcelain K; Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, 69120 Heidelberg, Germany.
  • Gárate-Calderón V; Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Santiago 8380000, Chile.
  • Waldenberger M; Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, 69120 Heidelberg, Germany.
  • Morales E; Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Santiago 8380000, Chile.
  • Rojas A; Research Unit Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Munoz C; Hospital Regional de Talca, Talca 3460000, Chile.
  • Retamales J; Facultad de Medicina, Universidad Católica del Maule, Talca 3460000, Chile.
  • De Toro G; Facultad de Medicina, Universidad Católica del Maule, Talca 3460000, Chile.
  • Kortmann AV; Hospital Regional de Talca, Talca 3460000, Chile.
  • Barajas O; Facultad de Medicina, Universidad Católica del Maule, Talca 3460000, Chile.
  • Rivera MT; Instituto Nacional del Cáncer, Santiago 7500650, Chile.
  • Cortés A; Hospital de Puerto Montt, Puerto Montt 5480000, Chile.
  • Loader D; Escuela de Tecnología Médica, Universidad Austral de Chile sede Puerto Montt, Puerto Montt 5480000, Chile.
  • Saavedra J; Hospital de Puerto Montt, Puerto Montt 5480000, Chile.
  • Gutiérrez L; Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Santiago 8380000, Chile.
  • Ortega A; Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
  • Bertrán ME; Hospital del Salvador, Santiago 7500922, Chile.
  • Bartolotti L; Hospital del Salvador, Santiago 7500922, Chile.
  • Gabler F; Hospital Padre Hurtado, Santiago 8880456, Chile.
  • Campos M; Hospital Padre Hurtado, Santiago 8880456, Chile.
  • Alvarado J; Hospital San Juan de Dios, Santiago 8320000, Chile.
  • Moisán F; Hospital Regional, Arica 1000000, Chile.
  • Spencer L; Unidad Registro Hospitalario de Cáncer, Hospital Base de Valdivia, Valdivia 5090146, Chile.
  • Nervi B; Hospital Base de Valdivia, Valdivia 5090000, Chile.
  • Carvajal D; Hospital San Borja Arriarán, Santiago 8320000, Chile.
  • Losada H; Hospital San Borja Arriarán, Santiago 8320000, Chile.
  • Almau M; Hospital Regional Guillermo Grant Benavente, Concepción 4070386, Chile.
  • Fernández P; Hospital Regional Guillermo Grant Benavente, Concepción 4070386, Chile.
  • Olloquequi J; Hospital Regional Guillermo Grant Benavente, Concepción 4070386, Chile.
  • Carter AR; Departamento de Hematología y Oncología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.
  • Miquel Poblete JF; Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7650568, Chile.
  • Bustos BI; Departamento de Cirugía, Universidad de la Frontera, Temuco 4780000, Chile.
  • Fuentes Guajardo M; Hospital de Rancagua, Rancagua 2820000, Chile.
  • Gonzalez-Jose R; Hospital de Rancagua, Rancagua 2820000, Chile.
  • Bortolini MC; Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.
  • Acuña-Alonzo V; Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca 3460000, Chile.
  • Gallo C; MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 1UD, UK.
  • Ruiz Linares A; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago 8320000, Chile.
  • Rothhammer F; Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.
  • Lorenzo Bermejo J; Departamento de Tecnología Médica, Facultad de Ciencias de la Salud, Tarapacá University, Arica 1000815, Chile.
Cancers (Basel) ; 15(16)2023 Aug 09.
Article em En | MEDLINE | ID: mdl-37627062
ABSTRACT
A strong association between the proportion of indigenous South American Mapuche ancestry and the risk of gallbladder cancer (GBC) has been reported in observational studies. Chileans show the highest incidence of GBC worldwide, and the Mapuche are the largest indigenous people in Chile. We set out to assess the confounding-free effect of the individual proportion of Mapuche ancestry on GBC risk and to investigate the mediating effects of gallstone disease and body mass index (BMI) on this association. Genetic markers of Mapuche ancestry were selected based on the informativeness for assignment measure, and then used as instrumental variables in two-sample Mendelian randomization analyses and complementary sensitivity analyses. Results suggested a putatively causal effect of Mapuche ancestry on GBC risk (inverse variance-weighted (IVW) risk increase of 0.8% per 1% increase in Mapuche ancestry proportion, 95% CI 0.4% to 1.2%, p = 6.7 × 10-5) and also on gallstone disease (3.6% IVW risk increase, 95% CI 3.1% to 4.0%), pointing to a mediating effect of gallstones on the association between Mapuche ancestry and GBC. In contrast, the proportion of Mapuche ancestry showed a negative effect on BMI (IVW estimate -0.006 kg/m2, 95% CI -0.009 to -0.003). The results presented here may have significant implications for GBC prevention and are important for future admixture mapping studies. Given that the association between the individual proportion of Mapuche ancestry and GBC risk previously noted in observational studies appears to be free of confounding, primary and secondary prevention strategies that consider genetic ancestry could be particularly efficient.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article